Radius Health, Inc.
- Country
- 🇺🇸United States
- Ownership
- Holding, Public
- Established
- 2003-11-01
- Employees
- 293
- Market Cap
- -
- Website
- http://radiuspharm.com
Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women
- First Posted Date
- 2021-07-23
- Last Posted Date
- 2024-04-19
- Lead Sponsor
- Radius Health, Inc.
- Target Recruit Count
- 22054
- Registration Number
- NCT04974723
- Locations
- 🇺🇸
Radius Health, Boston, Massachusetts, United States
Study to Evaluate and Compare the Bioequivalence of Two Abaloparatide-sMTS Treatments in Healthy Women.
- Conditions
- Interventions
- First Posted Date
- 2021-06-23
- Last Posted Date
- 2022-01-06
- Lead Sponsor
- Radius Health, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT04936984
- Locations
- 🇺🇸
Medpace Clinical Pharmacology, Cincinnati, Ohio, United States
Study to Evaluate and Compare the PK Profiles of Abaloparatide-SC and Abaloparatide-sMTS in a Cohort of Healthy Men and Healthy Women.
- Conditions
- Interventions
- First Posted Date
- 2020-12-11
- Last Posted Date
- 2022-01-06
- Lead Sponsor
- Radius Health, Inc.
- Target Recruit Count
- 52
- Registration Number
- NCT04663464
- Locations
- 🇺🇸
Medpace Clinical Pharmacology, Cincinnati, Ohio, United States
Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopausal Women With Low Bone Mineral Density (BMD)
- Conditions
- Interventions
- First Posted Date
- 2020-04-29
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- Radius Health, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT04366726
- Locations
- 🇺🇸
Pharmaceutical Research Associates, Inc, Lenexa, Kansas, United States
Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis
- Conditions
- Interventions
- First Posted Date
- 2019-08-21
- Last Posted Date
- 2023-02-15
- Lead Sponsor
- Radius Health, Inc.
- Target Recruit Count
- 511
- Registration Number
- NCT04064411
- Locations
- 🇺🇸
Shrock Orthopaedic Research, LLC, Fort Lauderdale, Florida, United States
🇺🇸Orthopedic Physician Alaska - Rheumatology, Anchorage, Alaska, United States
🇺🇸Arizona Arthritis & Rheumatology Research, PLLC, Mesa, Arizona, United States
Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption
- First Posted Date
- 2018-10-18
- Last Posted Date
- 2021-10-15
- Lead Sponsor
- Radius Health, Inc.
- Target Recruit Count
- 23
- Registration Number
- NCT03710889
- Locations
- 🇺🇸
Panorama Orthopedics & Spine Center, Golden, Colorado, United States
🇺🇸Center for Advanced Research & Education, Gainesville, Georgia, United States
🇺🇸Harvard Medical School, Boston, Massachusetts, United States
Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)
- First Posted Date
- 2018-04-30
- Last Posted Date
- 2023-04-07
- Lead Sponsor
- Radius Health, Inc.
- Target Recruit Count
- 228
- Registration Number
- NCT03512262
- Locations
- 🇺🇸
Meridian Clinical Research, Savannah, Georgia, United States
🇺🇸The University of Chicago, Chicago, Illinois, United States
🇺🇸SUNY Upstate Medical University, Syracuse, New York, United States
Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis
- First Posted Date
- 2012-08-29
- Last Posted Date
- 2020-06-16
- Lead Sponsor
- Radius Health, Inc.
- Target Recruit Count
- 250
- Registration Number
- NCT01674621
Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis
- First Posted Date
- 2012-08-06
- Last Posted Date
- 2020-12-11
- Lead Sponsor
- Radius Health, Inc.
- Target Recruit Count
- 1139
- Registration Number
- NCT01657162
Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women
- Conditions
- Interventions
- First Posted Date
- 2011-04-27
- Last Posted Date
- 2017-03-01
- Lead Sponsor
- Radius Health, Inc.
- Target Recruit Count
- 2463
- Registration Number
- NCT01343004